[1] 王小红, 亓波, 孙世元, 等. 冠状动脉CT对疑似冠心病患者长期心血管事件预测价值的研究[J]. 中国实验诊断学, 2017, 17(9):1627-1630. Wang X H, Bi B, Sun S Y, et al. Study on the predictive value of coronary CT for long-term cardiovascular events in patients with suspected coronary heart disease[J]. Chinese Experimental Diagnostics, 2017, 17(9):1627-1630.
[2] 杨文兵, 查云飞, 阳朝晖, 等. 冠脉CTA评估冠状动脉斑块性质及其与炎症分子、MMPs/TIMPs的相关性[J]. 海南医学院学报, 2017, 23(21):2929-2932. Yang W B, Zha Y F, Yang Z H, et al. Assessment of coronary plaque properties and its relationship with inflammatory molecules and MMPs/TIMPs by coronary CTA[J]. Journal of Hainan Medical College, 2017, 23(21):2929-2932.
[3] 巩贵红. 联合应用冠脉CTA与血清脂联素、肿瘤坏死因子-α检测对冠状动脉粥样硬化性心脏病患者斑块的诊断价值[J]. 国际心血管病杂志, 2017, 44(a01):135-136. Gong G H. Diagnostic value of combined use of coronary CTA, serum adiponectin and tumor necrosis factor-α for plaque in patients with coronary atherosclerotic heart disease[J]. International Journal of Cardiovascular Disease, 2017, 44(a01):135-136.
[4] 吴红虎, 王大伟. 冠脉CTA在肥厚型心脏病存在心绞痛患者中的应用价值[J]. 中国CT和MRI杂志, 2016, 14(2):64-68. Wu H H, Wang D W. The value of coronary CTA in patients with angina pectoris with hypertrophic heart disease[J]. Chinese Journal of CT and MRI, 2016, 14(2):64-68.
[5] 孙毅, 周海军, 方婷, 等. 运用128层宝石能谱CT探讨斑块性质与心绞痛类型相关性研究[J].中国医师杂志, 2017, 19(5):697-700. Sun Y, Zhou H J, Fang T, et al. Study on the correlation between plaque properties and angina pectoris using 128-layer gem spectroscopy CT[J]. Chinese Journal of Physician, 2017, 19(5):697-700.
[6] Egeberg A, Gislason G H, Hansen P R. Risk of major adverse cardiovascular events and all-cause mortality in patients with Hidradenitis Suppurativa[J]. Jama Dermatology, 2016, 152(4):429-434.
[7] Witberg G, Ayers C R, Turer A T, et al. Relation of adiponectin to all-cause mortality, cardiovascular mortality, and major adverse cardiovascular events (from the Dallas heart study)[J]. American Journal of Cardiology, 2016, 117(4):574-579.
[8] Wu S, Wu F, Ding Y, Hou J. Association of non-alcoholic fatty liver disease with major adverse cardiovascular events:a systematic review and meta-analysis[J]. Scientific Reports, 2016, 32(6):33386.
[9] Nissen S E, Wolski K E, Prcela L, et al. Effect of naltrexone-bupropion on major adverse cardiovascular events in overweight and obese patients with cardiovascular risk factors:a randomized clinical trial[J]. The Journal of the American Medical Association, 2016, 315(10):990-1004.
[10] 宁艺, 董光, 耿海,等. 双源CT冠状动脉成像对2型糖尿病患者心血管事件的预测价值[J]. 医学影像学杂志, 2016, 26(01):47-50. Ning Y, Dong G, Geng H, et al. Predictive value of dual-source CT coronary angiography in cardiovascular events in patients with type 2 diabetes[J]. Journal of Medical Imaging, 2016, 26(01):47-50.
[11] 丁辉. 64排螺旋CT冠脉成像(CTA)在冠心病诊断中的应用价值分析[J].中国实验诊断学, 2016, (2):224-226. Ding H. Application of 64-slice spiral CT coronary angiography (CTA) in the diagnosis of coronary heart disease[J]. Chinese Journal of Laboratory Diagnosis, 2016, (2):224-226.
[12] 刘帅,林闽江,许亚飞. 冠状动脉CT血管造影定量分析预测冠心病患者心血管事件风险的价值[J].中华全科医学, 2019, 17(8):1320-1322,1407. Liu S, Lin M J, Xu Y F. Value of quantitative analysis of coronary CT angiography in predicting the risk of cardiovascular events in patients with coronary heart disease[J]. Chinese General Practice, 2019, 17(8):1320-1322,1407.
[13] Lee Y T, Laxton V, Lin H Y, et al. Animal models of atherosclerosis[J]. Biomedical Reports, 2017, 6(3):259.
[14] Gimbrone Jr M A, Garcíacardeña G. Endothelial cell dysfunction and the pathobiology of atherosclerosis[J]. Circulation Research, 2016, 118(4):620-636.
[15] Herrington W, Lacey B, Sherliker P, et al. Epidemiology of atherosclerosis and the potential to reduce the global burden of atherothrombotic disease[J]. Circulation Research, 2016, 118(4):535.
[16] Tabas I, Bornfeldt K E. Macrophage phenotype and function in different stages of atherosclerosis[J]. Circulation Research, 2016, 118(4):653. |